Vieworks Co., Ltd.
₩26,750-₩950 (-3.43%)
Vieworks Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
KSC · 004080.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Shinhung Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 12.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shinhung Co., Ltd’s forward annual dividend is ₩360 per share, paid semi-annual. The forward yield is 2.49% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shinhung Co., Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating primarily in South Korea, Shinhung Co., Ltd. specializes in the production and distribution of a comprehensive array of dental goods and supplies. Their extensive product line features sophisticated implant systems and related components, essential clinical setups including dental units, chairs, and operatories, as well as critical sterilization and diagnostic equipment such as autoclaves and X-ray machines. They also provide disposable needles and various laboratory provisions like dental porcelain powders and alloys. Furthermore, the company offers a range of specialized cabinetry, encompassing drawer, equipment, sink, and mobile units, alongside other vital apparatus like compressors and mixers. Beyond its manufacturing and sales activities, Shinhung extends financial assistance to dental professionals through loan services. Established in 1955, the company's main operations are directed from its headquarters in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:49 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩26,750-₩950 (-3.43%)
Vieworks Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
₩3,050+₩80 (+2.69%)
MedPacto, Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.74% below the high.
₩6,720-₩60 (-0.88%)
Jeil Pharma Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 31.78% below the high.
₩2,790-₩85 (-2.96%)
iNtRON Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.2% below the high.
₩12,330-₩20 (-0.16%)
CKD Bio Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.48% below the high.
₩2,095-₩50 (-2.33%)
DongKook Life Science’s quoted price sits in the lower half of its reported 52-week range, 49.03% below the high.
₩841-₩36 (-4.1%)
CG Invites Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.55% below the high.
₩2,330-₩55 (-2.31%)
HUMASIS Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.35% below the high.